Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T21:11:37.000Z thumbnail image
  5. Check
    31 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T10:16:53.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T09:29:37.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T23:44:12.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T18:49:55.000Z thumbnail image
  10. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:51:31.000Z thumbnail image

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.